|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 329.40 SEK | +0.43% |
|
0.00% | +6.37% |
| 08/07 | Lancelot Sweden fell 0.8% in June, BioArctic slid despite Eli Lilly deal | FW |
| 01/07 | Alzecure CEO on the multibillion-dollar deal: 'QuantumCell can get products to market quickly' | FW |
Insider Transaction History
Latest insider transactions for BioArctic AB
| Date | Insider | Type | Main position | Quantity | Price | Amount | % Market Cap. | |
|---|---|---|---|---|---|---|---|---|
| 20/02 | Sell | Chief Executive Officer | 10,000 | 359.77 | 35.98L | 0.0135% | ||
| 20/02 | Fiscal year | Chief Executive Officer | 10,000 | - | - | 0.0135% | ||
| 20/02 | Fiscal year | 3,000 | - | - | 0.0040% | |||
| 20/02 | Fiscal year | 3,000 | 94.19 | 3L | 0.0040% | |||
| 20/02 | Fiscal year | Chief Executive Officer | 10,000 | 129.82 | 12.98L | 0.0135% | ||
| 20/02 | Sell | 3,000 | 359.77 | 10.79L | 0.0040% | |||
| 19/12 | Sell | Founder | 1,73,750 | 310.00 | 5.39Cr | 0.2340% | ||
| 19/12 | Sell | Founder | 1,73,750 | 310.00 | 5.39Cr | 0.2340% | ||
| 12/12 | Sell | Executive/Senior Manager | 500 | 316.40 | 2L | 0.0007% | ||
| 12/12 | Buy | Executive/Senior Manager | 500 | 318.40 | 2L | 0.0007% | ||
| 04/12 | Sell | 1,000 | 319.60 | 3L | 0.0013% | |||
| 05/25/05 | Sell | Founder | 12,00,000 | 300.00 | 36Cr | 1.6291% | ||
| 05/25/05 | Sell | Founder | 12,00,000 | 300.00 | 36Cr | 1.6291% | ||
| 31/25/31 | Fiscal year | Investor Relations Manager | 4,000 | - | - | 0.0054% | ||
| 31/25/31 | Fiscal year | Investor Relations Manager | 4,000 | 60.19 | 2L | 0.0054% | ||
| 31/25/31 | Sell | Investor Relations Manager | 3,000 | 295.20 | 9L | 0.0041% | ||
| 31/25/31 | Sell | Investor Relations Manager | 4,000 | 301.87 | 12.07L | 0.0054% | ||
| 31/25/31 | Sell | Investor Relations Manager | 941 | 309.20 | 3L | 0.0013% | ||
| 29/25/29 | Sell | Chief Executive Officer | 2,087 | 287.90 | 6L | 0.0028% | ||
| 29/25/29 | Fiscal year | 3,000 | - | - | 0.0041% | |||
| 29/25/29 | Sell | Chief Executive Officer | 10,713 | 289.41 | 31L | 0.0145% | ||
| 29/25/29 | Fiscal year | Chief Executive Officer | 30,000 | - | - | 0.0407% | ||
| 29/25/29 | Fiscal year | 3,000 | 94.19 | 3L | 0.0041% | |||
| 29/25/29 | Fiscal year | Chief Executive Officer | 30,000 | 129.82 | 38.95L | 0.0407% | ||
| 29/25/29 | Fiscal year | Executive/Senior Manager | 10,000 | 124.80 | 12.48L | 0.0136% | ||
| 29/25/29 | Sell | Executive/Senior Manager | 10,000 | 301.87 | 30.19L | 0.0136% | ||
| 29/25/29 | Fiscal year | Executive/Senior Manager | 10,000 | - | - | 0.0136% | ||
| 29/25/29 | Sell | Chief Executive Officer | 30,000 | 301.87 | 90.56L | 0.0407% | ||
| 29/25/29 | Sell | 3,000 | 301.87 | 9L | 0.0041% | |||
| 04/25/04 | Buy | Investor Relations Manager | 1,750 | 194.10 | 3L | 0.0024% | ||
| 04/25/04 | Sell | Investor Relations Manager | 1,750 | 194.20 | 3L | 0.0024% | ||
| 16/25/16 | Buy | Investor Relations Manager | 198 | 163.20 | 32.31T | 0.0003% | ||
| 16/25/16 | Buy | Chief Financial Officer | 500 | 164.70 | 82.35T | 0.0007% | ||
| 16/25/16 | Buy | Director | 2,422 | 163.20 | 4L | 0.0033% | ||
| 11/25/11 | Sell | Director | 5,730 | 221.71 | 12.7L | 0.0078% | ||
| 11/25/11 | Sell | Director | 21,540 | 220.07 | 47.4L | 0.0292% | ||
| 10/25/10 | Buy | Director | 448 | 222.40 | 99.64T | 0.0006% | ||
| 17/25/17 | Fiscal year | Chief Technology Officer | 2,500 | 83.60 | 2L | 0.0034% | ||
| 17/25/17 | Sell | Chief Technology Officer | 1,500 | 220.53 | 3L | 0.0020% | ||
| 17/25/17 | Fiscal year | Chief Technology Officer | 1,500 | - | - | 0.0020% | ||
| 17/25/17 | Sell | Chief Executive Officer | 40,000 | 220.53 | 88.21L | 0.0543% | ||
| 17/25/17 | Fiscal year | Chief Executive Officer | 40,000 | - | - | 0.0543% | ||
| 17/25/17 | Fiscal year | Chief Technology Officer | 2,500 | - | - | 0.0034% | ||
| 17/25/17 | Buy | Investor Relations Manager | 640 | 226.20 | 1L | 0.0009% | ||
| 17/25/17 | Sell | Investor Relations Manager | 1,600 | 226.40 | 4L | 0.0022% | ||
| 17/25/17 | Fiscal year | Chief Executive Officer | 40,000 | 83.60 | 33.44L | 0.0543% | ||
| 17/25/17 | Fiscal year | Chief Technology Officer | 1,500 | 83.60 | 1L | 0.0020% | ||
| 17/25/17 | Buy | Investor Relations Manager | 837 | 226.00 | 2L | 0.0011% | ||
| 13/25/13 | Sell | 6,000 | 220.53 | 13.23L | 0.0081% | |||
| 13/25/13 | Fiscal year | 6,000 | 83.60 | 5L | 0.0081% | |||
- Stock Market
- Stocks
- BIOA B Stock
- Company BioArctic AB
- Insider transactions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition